European healthcare policies for controlling drug expenditure.
- 1 January 2003
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (2) , 89-103
- https://doi.org/10.2165/00019053-200321020-00002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Impact of Selective Financing of Drugs on Pharmaceutical Expenditure Control in the Province of Valladolid, SpainPharmacoEconomics, 1996
- Healthcare Reform and Expenditure on DrugsPharmacoEconomics, 1996
- Cost Sharing for Pharmaceuticals - The Swedish Reimbursement SystemPharmacoEconomics, 1996
- Consequences of Implementing a Drug Budget for Office-Based Physicians in GermanyPharmacoEconomics, 1996
- Drug Pricing and Reimbursement in FrancePharmacoEconomics, 1996
- Are National Drug Expenditure Control Policies Compatible with a Single European Market?PharmacoEconomics, 1996
- New Developments in Pricing and Drug Reimbursement in FrancePharmacoEconomics, 1994
- Recent Public Policies in The Netherlands to Control Pharmaceutical Pricing and ReimbursementPharmacoEconomics, 1994
- The Influence of Pharmacoeconomic Factors on Prescribing Patterns in IrelandPharmacoEconomics, 1992
- Payment Restrictions for Prescription Drugs under MedicaidNew England Journal of Medicine, 1987